Suchergebnisse - "Bylicki, Olivier"

PubPharm (70)

31

Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2

enthalten in: European journal of clinical microbiology & infectious diseases | 2021

von Plantamura, J. | Bousquet, A. | Otto, M. | +14

32

Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2

enthalten in: European journal of clinical microbiology & infectious diseases | 2021

von Plantamura, J. | Bousquet, A. | Otto, M. | +14

33

Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care

enthalten in: Clinical lung cancer | 2021

von Bylicki, O. | Rivière, F. | Tournier, C. | +7

34

An Outbreak of Covid-19 on an Aircraft Carrier

enthalten in: The New England journal of medicine | 2021

von Bylicki, O. | Paleiron, N. | Janvier, F.

CommentOn: N Engl J Med. 2020 Dec 17;383(25):2417-2426. - PMID 33176077

35

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

enthalten in: Cancers | 2021

von Gounant, V. | Duruisseaux, M. | Soussi, G. | +14

36

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

enthalten in: Haematologica | 2020

von Boudin, L. | Janvier, F. | Bylicki, O. | +1

CommentOn: Br J Haematol. 2020 Jul;190(1):24-27. - PMID 32379894

37

Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation : GFPC 01-2018

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Guisier, F. | Dubos-Arvis, C. | Viñas, F. | +15

CommentIn: J Thorac Oncol. 2020 Apr;15(4):489-492. - PMID 32216943

38

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma

enthalten in: Medicine | 2020

von Bylicki, O. | Guisier, F. | Monnet, I. | +8

39

Targeting the MET-Signaling Pathway in Non-Small-Cell Lung Cancer : Evidence to Date

enthalten in: OncoTargets and therapy | 2020

von Bylicki, O. | Paleiron, N. | Assié, J. | +1

40

Lung cancer and end-of-life care : a systematic review and thematic synthesis of aggressive inpatient care

enthalten in: BMJ supportive & palliative care | 2019

von Bylicki, O. | Didier, M. | Riviere, F. | +3